Showing results (161-170 of 167) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
The Journal of Infectious Diseases|May 11, 2022
Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019Shilpa Hakre, Ines Lakhal-Naouar, David B King, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national studyFaris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.The Lancet. Microbe|May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trialBrittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.Antimicrobial Agents and Chemotherapy|August 16, 2017
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii InfectionRobert T Schooley, Biswajit Biswas, Jason J Gill, et al.Emerging Microbes & Infections|December 13, 2023
Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern NigeriaAnise Nkenjop Happi, Olusola Akinola Ogunsanya, Akeemat Opeyemi Ayinla, et al.BMC Infectious Diseases|October 7, 2024
Seroprevalence and risk factors for Lassa virus infection in South-West and North-Central Nigeria: a community-based cross-sectional studyAbdulwasiu B Tiamiyu, Olutunde A Adegbite, Olivia Freides, et al.Lancet (London, England)|January 28, 2023
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trialMelinda J Hamer, Katherine V Houser, Amelia R Hofstetter, et al.Pageof 17